Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vatrano

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Giornale Italiano Di Cardiologia (2006)|February 27, 2020
[Diagnostic and therapeutic models for the management of acute pulmonary embolism: an issue of local available resources]Loris Roncon, Claudio Picariello, Marco Vatrano, et al.
Molecular and Cellular Biochemistry|February 13, 2017
Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertensionEgidio Imbalzano, Marco Vatrano, Sebastiano Quartuccio, et al.
Journal of Clinical Medicine|January 11, 2022
Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active CancerEgidio Imbalzano, Luana Orlando, Angela Sciacqua, et al.
Biomedicines|February 25, 2022
Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome PatientsEgidio Imbalzano, Giuseppina T Russo, Annalisa Giandalia, et al.
Giornale Italiano Di Cardiologia (2006)|November 22, 2016
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism]Iolanda Enea, Loris Roncon, Michele Massimo Gulizia, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO Position Paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and preventionIolanda Enea, Loris Roncon, Michele Massimo Gulizia, et al.
Giornale Italiano Di Cardiologia (2006)|January 25, 2024
[Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment]Sergio Caravita, Mauro Gori, Andrea Garascia, et al.
Giornale Italiano Di Cardiologia (2006)|November 8, 2019
[ANMCO statement: Arterial and venous thromboembolism: what implications for clinical practice?]Maurizio Giuseppe Abrignani, Iolanda Enea, Furio Colivicchi, et al.
Giornale Italiano Di Cardiologia (2006)|February 27, 2024
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension]Marco Vatrano, Giovanna Manzi, Claudio Picariello, et al.
International Journal of Cardiology|November 26, 2020
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registryGiuseppe Ciliberti, Monica Verdoia, Marco Merlo, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Giornale Italiano Di Cardiologia (2006)|February 27, 2020
[Diagnostic and therapeutic models for the management of acute pulmonary embolism: an issue of local available resources]Loris Roncon, Claudio Picariello, Marco Vatrano, et al.
Molecular and Cellular Biochemistry|February 13, 2017
Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertensionEgidio Imbalzano, Marco Vatrano, Sebastiano Quartuccio, et al.
Journal of Clinical Medicine|January 11, 2022
Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active CancerEgidio Imbalzano, Luana Orlando, Angela Sciacqua, et al.
Biomedicines|February 25, 2022
Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome PatientsEgidio Imbalzano, Giuseppina T Russo, Annalisa Giandalia, et al.
Giornale Italiano Di Cardiologia (2006)|November 22, 2016
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism]Iolanda Enea, Loris Roncon, Michele Massimo Gulizia, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO Position Paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and preventionIolanda Enea, Loris Roncon, Michele Massimo Gulizia, et al.
Giornale Italiano Di Cardiologia (2006)|January 25, 2024
[Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment]Sergio Caravita, Mauro Gori, Andrea Garascia, et al.
Giornale Italiano Di Cardiologia (2006)|November 8, 2019
[ANMCO statement: Arterial and venous thromboembolism: what implications for clinical practice?]Maurizio Giuseppe Abrignani, Iolanda Enea, Furio Colivicchi, et al.
Giornale Italiano Di Cardiologia (2006)|February 27, 2024
[ANMCO/SIC Consensus statement on pulmonary arterial hypertension]Marco Vatrano, Giovanna Manzi, Claudio Picariello, et al.
International Journal of Cardiology|November 26, 2020
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registryGiuseppe Ciliberti, Monica Verdoia, Marco Merlo, et al.
Pageof 4